Related Experiment Video

Updated: Jul 18, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

RNASEN regulates cell proliferation and affects survival in esophageal cancer patients

Nobuyoshi Sugito1, Hideyuki Ishiguro, Yoshiyuki Kuwabara

  • 1Department of Surgery II, Nagoya City University Medical School, Nagoya, Japan.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|November 24, 2006
PubMed
Abstract

Insights

RNASEN enzyme expression is elevated in esophageal squamous cell carcinoma (ESCC) and correlates with poor prognosis. Reducing RNASEN levels inhibits cancer cell proliferation, suggesting its role in tumor progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
  • The role of miRNAs in normal and cancer cells is not fully understood.
  • miRNA deregulation may contribute to oncogenesis.

Purpose of the Study:

  • To investigate the expression of miRNA processing enzymes (DICER1, DGCR8, RNASEN) in esophageal squamous cell carcinoma (ESCC).
  • To assess the prognostic significance of RNASEN in ESCC.
  • To evaluate the functional role of RNASEN in ESCC cell proliferation.

Main Methods:

  • Quantitative real-time reverse-transcription PCR to measure mRNA levels of DICER1, DGCR8, and RNASEN in ESCC tissues and normal epithelium.
  • Western blot and immunohistochemistry to assess RNASEN protein expression.
  • Small interfering RNA (siRNA) to knockdown RNASEN and assess its effect on ESCC cell proliferation.

Main Results:

  • RNASEN mRNA and protein expression were elevated in a subset of ESCC tissues compared to normal esophageal epithelium.
  • Higher RNASEN expression was significantly associated with poorer prognosis in ESCC patients, independent of disease stage.
  • Knockdown of RNASEN in ESCC cell lines led to a substantial reduction in cell proliferation (46%-85%).

Conclusions:

  • RNASEN is upregulated in ESCC and its expression level is a potential prognostic marker.
  • RNASEN plays a role in promoting ESCC cell proliferation.
  • Further research is warranted to explore the role of miRNA processing enzymes in ESCC progression.

More Related Videos

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion10:42

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

Published on: July 6, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.